Viruses and thyroiditis: an update

Rachel Desailloud, Didier Hober, Rachel Desailloud, Didier Hober

Abstract

Viral infections are frequently cited as a major environmental factor involved in subacute thyroiditis and autoimmune thyroid diseases This review examines the data related to the role of viruses in the development of thyroiditis. Our research has been focused on human data. We have reviewed virological data for each type of thyroiditis at different levels of evidence; epidemiological data, serological data or research on circulating viruses, direct evidence of thyroid tissue infection. Interpretation of epidemiological and serological data must be cautious as they don't prove that this pathogen is responsible for the disease. However, direct evidence of the presence of viruses or their components in the organ are available for retroviruses (HFV) and mumps in subacute thyroiditis, for retroviruses (HTLV-1, HFV, HIV and SV40) in Graves's disease and for HTLV-1, enterovirus, rubella, mumps virus, HSV, EBV and parvovirus in Hashimoto's thyroiditis. However, it remains to determine whether they are responsible for thyroid diseases or whether they are just innocent bystanders. Further studies are needed to clarify the relationship between viruses and thyroid diseases, in order to develop new strategies for prevention and/or treatment.

References

    1. Prummel M, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150:605–618.
    1. Nishihara E, Ohye H, Amino N, Takata K, Arishima T, Kudo T, Ito M, Kubota S, Fukata S, Miyauchi A. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008;47:725–729.
    1. Kojima M, Nakamura S, Oyama T, Sugihara S, Sakata N, Masawa N. Cellular composition of subacute thyroiditis: an immunohistochemical study of six cases. Pathol Res Pract. 2002;198:833–837.
    1. Volpe R. Thyroiditis: current views of pathogenesis. Med Clin North Am. 1975;59:1163–1175.
    1. Martino E, Buratti L, Bartalena L, Mariotti S, Cupini C, Aghini-Lombardi F, Pinchera A. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest. 1987;10:321–323.
    1. de Bruin TW, Riekhoff FP, de Boer JJ. An outbreak of thyrotoxicosis due to atypical subacute thyroiditis. J Clin Endocrinol Metab. 1990;70:396–402.
    1. Nyulassy S, Hnilica P, Buc M, Guman M, Hirschova V, Stefanovic J. Subacute (de Quervain's) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J Clin Endocrinol Metab. 1977;45:270–274.
    1. Kramer AB, Roozendaal C, Dullaart RP. Familial occurrence of subacute thyroiditis associated with human leukocyte antigen-B35. Thyroid. 2004;14:544–547.
    1. Yamamoto M, Saito S, Sakurada T, Tamura M, Kudo Y, Yoshida K, Kaise K, Kaise N, Fukazawa H, Itagaki Y, et al. Recurrence of subacute thyroiditis over 10 years after the first attack in three cases. Endocrinol Jpn. 1988;35:833–839.
    1. Kacprzak-Bergman I, Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch Immunol Ther Exp (Warsz) 2005;53:139–142.
    1. Roger M. Influence of host genes on HIV-1 disease progression. Faseb J. 1998;12:625–632.
    1. Klenerman P, Tolfvenstam T, Price DA, Nixon DF, Broliden K, Oxenius A. T lymphocyte responses against human parvovirus B19: small virus, big response. Pathol Biol (Paris) 2002;50:317–325.
    1. Sato M. Virus-like particles in the follicular epithelium of the thyroid from a patient with subacute thyroiditis (de Quervain's) Acta Pathol Jpn. 1975;25:499–501.
    1. Joasoo A, Robertson P, Murray IP. Letter: Viral antibodies in thyrotoxicosis. Lancet. 1975;2:125.
    1. Stancek D, Stancekova-Gressnerova M, Janotka M, Hnilica P, Oravec D. Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol. 1975;161:133–144.
    1. Stancek D, Ciampor F, Mucha V, Hnilica P, Stancekova M. Morphological, cytological and biological observations on viruses isolated from patients with subacute thyroiditis de Quervain. Acta Virol. 1976;20:183–188.
    1. Werner J, Gelderblom H. Isolation of foamy virus from patients with de Quervain thyroiditis. Lancet. 1979;2:258–259.
    1. Debons-Guillemin MC, Valla J, Gazeau J, Wybier-Franqui J, Giron ML, Toubert ME, Canivet M, Peries J. No evidence of spumaretrovirus infection markers in 19 cases of De Quervain's thyroiditis. AIDS Res Hum Retroviruses. 1992;8:1547.
    1. Wick G, Grubeck-Loebenstein B, Trieb K, Kalischnig G, Aguzzi A. Human foamy virus antigens in thyroid tissue of Graves' disease patients. Int Arch Allergy Immunol. 1992;99:153–156.
    1. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses. 1995;11:161–170.
    1. Meiering CD, Comstock KE, Linial ML. Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol. 2000;74:1718–1726.
    1. Eylan E, Zmucky RCS. Mumps virus and subacute thyroiditis. Evidence of a causal association. Lancet. 1957;272:1062–1067.
    1. Parmar RC, Bavdekar SB, Sahu DR, Warke S, Kamat JR. Thyroiditis as a presenting feature of mumps. Pediatr Infect D. 2001;20:637–638.
    1. Volpe R, Row VV, Ezrin C. Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab. 1967;27:1275–1284.
    1. Brouqui P, Raoult D, Conte-Devolx B. Coxsackie thyroiditis. Ann Intern Med. 1991;114:1063–1064.
    1. Luotola K, Hyoty H, Salmi J, Miettinen A, Helin H, Pasternack A. Evaluation of infectious etiology in subacute thyroiditis–lack of association with coxsackievirus infection. Apmis. 1998;106:500–504.
    1. Espino Montoro A, Medina Perez M, Gonzalez Martin MC, Asencio Marchante R, Lopez Chozas J. Subacute thyroiditis associated with positive antibodies to the Epstein-Barr virus. An Med Interna. 2000;17:546–548.
    1. Volta C, Carano N, Street ME, Bernasconi S. Atypical subacute thyroiditis caused by Epstein-Barr virus infection in a three-year-old girl. Thyroid. 2005;15:1189–1190.
    1. Al Maawali A, Al Yaarubi S, Al Futaisi A. An infant with cytomegalovirus-induced subacute thyroiditis. J Pediatr Endocrinol Metab. 2008;21:191–193.
    1. Mori K, Yoshida K, Funato T, Ishii T, Nomura T, Fukuzawa H, Sayama N, Hori H, Ito S, Sasaki T. Failure in detection of Epstein-Barr virus and cytomegalovirus in specimen obtained by fine needle aspiration biopsy of thyroid in patients with subacute thyroiditis. Tohoku J Exp Med. 1998;186:13–17.
    1. Nakamura S, Kosaka J, Sugimoto M, Watanabe H, Shima H, Takuno H. Silent thyroiditis following rubella. Endocrinol Jpn. 1990;37:79–85.
    1. Volpe R. The management of subacute (de Quervain's) thyroiditis. Thyroid. 1993;5:253–255.
    1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526–534.
    1. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F. The incidence of thyroid disorders in the community: a twenty year follow-up of the Whickam Survey. Clinical Endocrinology (Oxf) 1995;43:55–68.
    1. Tomer Y, Davies T. Infection, thyroid disease, and autoimmunity. Endocrine Rev. 1993;14:107–120.
    1. Davies TF. Infection and Autoimmune Thyroid Disease. J Clin Endocrinol Metab. 2008;93:674–676.
    1. Bach JF. [Infections and autoimmunity] Rev Med Interne. 2005;26:32–34.
    1. Kondrashova A, Viskari H, Haapala AM, Seiskari T, Kulmala P, Ilonen J, Knip M, Hyoty H. Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab. 2008;93:729–734.
    1. Harii N, Lewis CJ, Vasko V, McCall K, Benavides-Peralta U, Sun X, Ringel MD, Saji M, Giuliani C, Napolitano G, et al. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol Endocrinol. 2005;19:1231–1250.
    1. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–376.
    1. Misaki T, Iida Y, Kasagi K, Konishi J. Seasonal variation in relapse rate of graves' disease after thionamide drug treatment. Endocr J. 2003;50:669–672.
    1. Cox SP, Phillips DI, Osmond C. Does infection initiate Graves disease? A population based 10 year study. Autoimmunity. 1989;4:43–49.
    1. Phillips DI, Barker DJ, Rees Smith B, Didcote S, Morgan D. The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol (Oxf) 1985;23:283–287.
    1. Krassas GE, Tziomalos K, Pontikides N, Lewy H, Laron Z. Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol. 2007;156:631–636.
    1. Weetman AP, Smallridge RC, Nutman TB, Burman KD. Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol. 1987;23:1–6.
    1. Benker G, Olbricht T, Windeck R, Wagner R, Albers H, Lederbogen S, Hoff HG, Reinwein D. The sonographical and functional sequelae of de Quervain's subacute thyroiditis: long-term follow-up. Acta Endocrinol (Copenh) 1988;117:435–441.
    1. Wartofsky L, Schaaf M. Graves' disease with thyrotoxicosis following subacute thyroiditis. Am J Med. 1987;81:761–764.
    1. Perloff WH. Thyrotoxicosis following acute thyroiditis: a report of five cases. J Clin Endocrinol Metab. 1956;16:542–546.
    1. Werner SC. Graves' disease following acute (subacute) thyroiditis. Arch Intern Med. 1979;139:1313–1315.
    1. Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clin Endocrinol (Oxf) 1998;48:445–453.
    1. Lindberg B, Ahlfors K, Carlsson A, Ericsson UB, Landin-Olsson M, Lernmark A, Ludvigsson J, Sundkvist G, Ivarsson SA. Previous exposure to measles, mumps, and rubella–but not vaccination during adolescence–correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics. 1999;104:e12.
    1. Tomoyose T, Komiya I, Takara M, Yabiku K, Kinjo Y, Shimajiri Y, Yogi H, Kouki T, Masuda M, Takasu N. Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto thyroiditis in Japanese patients. Thyroid. 2002;12:673–677.
    1. Nakachi K, Takasu N, Akamine H, Komiya I, Ishikawa K, Shinjyo T, Masuda M. Association of HLTV-1 with autoimmune thyroiditis in patients with adult T-cell leukemia (ATL) and in HTLV-1 carriers and a patient of ATL with autoimmune thyroiditis and uveites. 6th Asia and Oceania Thyroid Association Congress; Osaka, Japan. 1997.
    1. Kawai H, Saito M, Takagi M, Tsuchihashi T, Arii Y, Kondo A, Iwasa M, Hirose T, Hizawa K, Saito S. Hashimoto's thyroiditis in HTLV-I carriers. Intern Med. 1992;31:1213–1216.
    1. Kawai H, Inui T, Kashiwagi S, Tsuchihashi T, Masuda K, Kondo A, Niki S, Iwasa M, Saito S. HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroiditis) J Med Virol. 1992;38:138–141.
    1. Akamine H, Takasu N, Komiya I, Ishikawa K, Shinjyo T, Nakachi K, Masuda M. Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers. Clin Endocrinol (Oxf) 1996;45:461–466.
    1. Matsuda T, Tomita M, Uchihara JN, Okudaira T, Ohshiro K, Tomoyose T, Ikema T, Masuda M, Saito M, Osame M, et al. Human T cell leukemia virus type I-infected patients with Hashimoto's thyroiditis and Graves' disease. J Clin Endocrinol Metab. 2005;90:5704–5710.
    1. Mine H, Kawai H, Yokoi K, Akaike M, Saito S. High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies. J Mol Med. 1996;74:471–477.
    1. Kawai H, Mitsui T, Yokoi K, Akaike M, Hirose K, Hizawa K, Saito S. Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis. J Mol Med. 1996;74:275–278.
    1. Mizokami T, Okamura K, Kohno T, Sato K, Ikenoue H, Kuroda T, Inokuchi K, Fujishima M. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole. J Clin Endocrinol Metab. 1995;80:1904–1907.
    1. Kawai H, Yokoi K, Akaike M, Kunishige M, Abe M, Tanouchi Y, Mine H, Mimura Y, Saito S. Graves' disease in HTLV-I carriers. J Mol Med. 1995;73:85–88.
    1. Sarui H, Sano A, Maruyama T, Nakashima K, Takeda N, Yasuda K. Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease. Am J Med Sci. 2002;324:109–114.
    1. Ono A, Ikeda E, Mochizuki M, Matsuoka M, Yamaguchi K, Sawada T, Yamane S, Tokudome S, Watanabe T. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res. 1998;89:608–614.
    1. Kubonishi I, Kubota T, Sawada T, Tanaka Y, Machida H, Yoshida O, Fukushima A, Ueno H, Ohtsuki Y, Miyoshi I. An HTLV-I carrier with Graves' disease followed by uveitis: isolation of HTLV-I from thyroid tissue. Int J Hematol. 1997;66:233–237.
    1. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1:329–337.
    1. Hoffmann CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis. 2007;45:488–494.
    1. Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, Arlot S, Schmit JL, Group TaV Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: a need for screening. Clin Infect Dis. 2003;37:579–583.
    1. Beltran S, Lescure F, El Esper I, Schmit JL, Desailloud R. Subclinical hypothyroidism in HIV-infected patients is not an autoimmune disease. Horm Res. 2006;66:21–26.
    1. Drabick JJ, Horning VL, Lennox JL, Coyne PE, Oster CN, Knight RD, Dillard TA, Fuller SA, Damato JJ, Burke DS. A retrospective analysis of diseases associated with indeterminate HIV western blot patterns. Mil Med. 1991;156:93–96.
    1. Ciampolillo A, Marini V, Mirakian R, Buscema M, Schulz T, Pujol-Borrell R, Bottazzo GF. Retrovirus-like sequences in Graves' disease: implications for human autoimmunity. Lancet. 1989;1:1096–1100.
    1. Nagasaka A, Nakai A, Oda N, Kotake M, Iwase K, Yoshida S. Reverse transcriptase is elevated in the thyroid tissue from Graves' disease patients. Clin Endocrinol (Oxf) 2000;53:155–159.
    1. Tominaga T, Katamine S, Namba H, Yokoyama N, Nakamura S, Morita S, Yamashita S, Izumi M, Miyamoto T, Nagataki S. Lack of evidence for the presence of human immunodeficiency virus type 1-related sequences in patients with Graves' disease. Thyroid. 1991;1:307–314.
    1. Humphrey M, Mosca J, Baker JR, Drabick JJ, Carr FE, Burke DS, Wartofsky L, Djuh YY, Burman KD. Absence of retroviral sequences in Graves' disease. Lancet. 1991;337:17–18.
    1. Burch HB, Nagy EV, Lukes YG, Cai WY, Wartofsky L, Burman KD. Nucleotide and amino acid homology between the human thyrotropin receptor and the HIV-1 Nef protein: identification and functional analysis. Biochem Biophys Res Commun. 1991;181:498–505.
    1. Knysz B, Bolanowski M, Klimczak M, Gladysz A, Zwolinska K. Graves' disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol. 2006;19:102–107.
    1. Chen F, Day SL, Metcalfe RA, Sethi G, Kapembwa MS, Brook MG, Churchill D, de Ruiter A, Robinson S, Lacey CJ, Weetman AP. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 2005;84:98–106.
    1. Kuff EL, Lueders KK. The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Res. 1988;51:183–276.
    1. Jaspan J, Sullivan K, Garry R, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander D, Ahmed B, Bryer-ash M. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves disease. J Clin Endocrinol Metab. 1996;81:2271–2279.
    1. Fierabracci A, Upton CP, Hajibagheri N, Bottazzo GF. Lack of detection of retroviral particles (HIAP-1) in the H9 T cell line co-cultured with thyrocytes of Graves' disease. J Autoimmun. 2001;16:457–462.
    1. Wick G, Trieb K, Aguzzi A, Recheis H, Anderl H, Grubeck-Loebenstein B. Possible role of human foamy virus in Graves' disease. Intervirology. 1993;35:101–107.
    1. Lagaye S, Vexiau P, Morozov V, Guenebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Cathelineau G, Peries J, Emanoil-Ravier R. Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proc Natl Acad Sci USA. 1992;89:10070–10074.
    1. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D. Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses. 1994;10:601–605.
    1. Yanagawa T, Ito K, Kaplan EL, Ishikawa N, DeGroot LJ. Absence of association between human spumaretrovirus and Graves' disease. Thyroid. 1995;5:379–382.
    1. Lee H, Kim S, Kang M, Kim W, Cho B. Prevalence of human foamy virus-related sequences in the Korean population. J Biomed Sci. 1998;5:267–273.
    1. Vivaldi A, Pacini F, Martini F, Laccheri L, Pezzetti F, Elisei R, Pinchera A, Faviana P, Basolo F, Tognon M. Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes. J Clin Endocrinol Metab. 2003;88:892–899.
    1. Ziring PR, Fedun BA, Cooper LZ. Thyrotoxicosis in congenital rubella. J Pediatr. 1975;87:1002.
    1. Ziring PR, Gallo G, Finegold M, Buimovici-Klein E, Ogra P. Chronic lymphocytic thyroiditis: identification of rubella virus antigen in the thyroid of a child with congenital rubella. J Pediatr. 1977;90
    1. Clarke WL, Shaver KA, Bright GM, Rogol AD, Nance WE. Autoimmunity in congenital rubella syndrome. J Pediatr. 1984;104:370–373.
    1. Ginsberg-Fellner F, Witt ME, Yagihashi S, Dobersen MJ, Taub F, Fedun B, McEvoy RC, Roman SH, Davies RG, Cooper LZ, et al. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia. 1984;27:87–89.
    1. Viskari H, Paronen J, Keskinen P, Simell S, Zawilinska B, Zgorniak-Nowosielska I, Korhonen S, Ilonen J, Simell O, Haapala AM, et al. Humoral beta-cell autoimmunity is rare in patients with the congenital rubella syndrome. Clin Exp Immunol. 2003;133:378–383.
    1. Forrest JM, Turnbull FM, Sholler GF, Hawker RE, Martin FJ, Doran TT, Burgess MA. Gregg's congenital rubella patients 60 years later. Med J Aust. 2002;177:664–667.
    1. Comas AP, Btances RE. Congenital rubella and acquired hypothyroidism secondary to Hashimoto's thyroiditis. J Pediatr. 1976;88:1065–1066.
    1. Nieburg PI, Gardner LI. Thyroiditis and congenital rubella syndrome. 1976;89:156.
    1. Hanid TK. Hypothyroidism in congenital rubella. Lancet. 1976;2:854.
    1. AvRuskin TW, Brakin M, Juan C. Congenital rubella and myxedema. Pediatrics. 1982;69:495.
    1. Schopfer K, Matter L, Flueler U, Werder E. Diabetes mellitus, endocrine autoantibodies, and prenatal rubella infection. Lancet. 1982;2:1593.
    1. Thomas D, Liakos V, Michou V, Kapranos N, Kaltsas G, Tsilivakos V, Tsatsoulis A. Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Exp Clin Endocrinol Diabetes. 2008;116:35–39.
    1. Swanson-Mungerson M, Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol. 2007;28:213–218.
    1. Vrbikova J, Janatkova I, Zamrazil V, Tomiska F, Fucikova T. Epstein-Barr virus serology in patients with autoimmune thyroiditis. Exp Clin Endocrinol Diabetes. 1996;104:89–92.
    1. Shimon I, Pariente C, Shlomo-David J, Grossman Z, Sack J. Transient elevation of triiodothyronine caused by triiodothyronine autoantibody associated with acute Epstein-Barr-virus infection. Thyroid. 2003;13:211–215.
    1. Leite JL, Bufalo NE, Santos RB, Romaldini JH, Ward LS. Human herpesvirus type 6 (HHV6) and type 7 (HHV7) may increase the susceptibility to Graves disease in individuals with inherited diminished TP53 apoptotic function. 33rd annual meeting of the european thyroid association; Thessalonique. 2008.
    1. Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003;2:218–223.
    1. Mori K, Munakata Y, Saito T, Tani J, Nakagawa Y, Hoshikawa S, Ozaki H, Ito S, Yoshida K. Intrathyroidal persistence of human parvovirus B19 DNA in a patient with Hashimoto's thyroiditis. J Infect. 2007;55:29–31.
    1. Lehmann HW, Lutterbuse N, Plentz A, Akkurt I, Albers N, Hauffa BP, Hiort O, Schoenau E, Modrow S. Association of parvovirus B19 infection and Hashimoto's thyroiditis in children. Viral Immunol. 2008;21:379–383.
    1. Hammond CJ, Hobbs JA. Parvovirus B19 infection of brain: Possible role of gender in determining mental illness and autoimmune thyroid disorders. Medical Hypothesis. 2007;69:113–116.
    1. Munakata Y, Kodera T, Saito T, Sasaki T. Rheumatoid arthritis, type 1 diabetes, and Graves' disease after acute parvovirus B19 infection. Lancet. 2005;366:780.
    1. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA, Zignego AL. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Digestive and Liver Disease. 2007;39:S13–S21.
    1. Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E. Thyroid disorders in chronic hepatitis C virus infection. Thyroid. 2006;16:563–572.
    1. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. Jama. 2007;297:2010–2017.
    1. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, Salmeron J. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during and after discontinuing interferon therapy. Arch Intern Med. 1998;158:1445–1448.
    1. Metcalfe RA, Ball G, Kudesia G, Weetman AP. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid. 1997;7:421–424.
    1. Nduwayo L, Bacq Y, Valat C, Goudeau A, Lecomte P. [Thyroid function and autoimmunity in 215 patients seropositive for the hepatitis C virus] Ann Endocrinol (Paris) 1998;59:9–13.
    1. Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, Garcia-Monzon C, Arranz A, Borque MJ, Moreno-Otero R. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 1996;44:635–642.
    1. Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet. 1991;338:277–280.
    1. Wang W, Ye YX, Yao H. Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chin Antituberculous Assoc. 2003;25:232–234.
    1. Rose NR, Herskowitz A, Neumann DA. Autoimmunity in myocarditis: models and mechanisms. Clin Immunol Immunopathol. 1993;2:95–99.
    1. Holl RW, Bohm B, Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Horm Res. 1999;52:113–118.
    1. Jaidane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008
    1. Desailloud R, Goffard A, Page C, Kairis B, Fronval S, Chatelain D, Strunski V, Dubreuil A, Hober D. Detection of enterovirus RNA in postoperative thyroid tissue specimens. Clin Endocrinol (Oxf) 2008
    1. Svensson J, Lindberg B, Jonsson B, Ericsson UB, Olofsson P, Hyoty H, Ivarsson SA. Intrauterine exposure to maternal enterovirus infection as a risk factor for development of autoimmune thyroiditis during childhood and adolescence. Thyroid. 2004;14:367–370.
    1. Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Luger C, Binder L, Mittermayer H. Enterovirus infection–a possible trigger for Graves' disease? Wien Klin Wochenschr. 2001;113:204–207.
    1. Srinivasappa J, Garzelli C, Onodera T, Ray U, Notkins A. Virus-induced thyroiditis. Endocrinology. 1988;122:563–566.
    1. Onodera T, Awaya A. Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice. Immunology. 1990;71:581–585.
    1. Ziemiecki A, Kromer G, Mueller RG, Hala K, Wick G. ev 22, a new endogenous avian leukosis virus locus found in chickens with spontaneous autoimmune thyroiditis. Arch Virol. 1988;100:267–271.
    1. Klavinskis L, Notkins A, Oldstone M. Persistent viral infection of the thyroid gland: alteration of thyroid function in the absence of tissue injury. Endocrinology. 1988;122:567–575.
    1. Lee SL, Ananthakrishnan S. Riedel's thyroiditis. In: Rose BE, editor. UpToDate. Waltham, MA: UpToDate; 2008.
    1. Kabalak T, Ozgen AG, Gunel O, Yetkin E. Occurrence of Riedel's thyroiditis in the course of sub-acute thyroiditis. J Endocrinol Invest. 2000;23:399–401.
    1. Cho MH, Kim CS, Park JS, Kang ES, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. Riedel's thyroiditis in a patient with recurrent subacute thyroiditis: a case report and review of the literature. Endocr J. 2007;54:559–562.
    1. Fontaine S, Gaches F, Lamant L, Uzan M, Bennet A, Caron P. An unusual form of Riedel's thyroiditis: a case report and review of the literature. Thyroid. 2005;15:85–88.
    1. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601–604.
    1. Lam KY, Lo CY, Kwong DL, Lee J, Srivastava G. Malignant lymphoma of the thyroid. A 30-year clinicopathologic experience and an evaluation of the presence of Epstein-Barr virus. Am J Clin Pathol. 1999;112:263–270.
    1. Tomita Y, Ohsawa M, Kanno H, Matsuzuka F, Kuma K, Aozasa K. Sporadic activation of Epstein-Barr virus in thyroid lymphoma. Leuk Lymphoma. 1995;19:129–134.
    1. Takahashi K, Kashima K, Daa T, Yokoyama S, Nakayama I, Noguchi S. Contribution of Epstein-Barr virus to development of malignant lymphoma of the thyroid. Pathol Int. 1995;45:366–374.
    1. Santoe MF, Van Houten AA, Muller AF, Berghout A. [A pregnant woman with autoimmune thyroiditis and recurrent goiter] Ned Tijdschr Geneeskd. 2004;148:1455–1459.
    1. Samuels MH, Launder T. Hyperthyroidism due to lymphoma involving the thyroid gland in a patient with acquired immunodeficiency syndrome: case report and review of the literature. Thyroid. 1998;8:673–677.
    1. Frache S, Peter MO, Laithier V, Bertrand AM, Thiriez G, Menget A, Kantelip B, Yakouben K, Plouvier E, Rohrlich PS. [Involvement of thyroid gland at non-Hodgkin lymphoma initial diagnosis: 2 pediatric cases] Arch Pediatr. 2006;13:38–40.
    1. Mizokami TOK, Kohno T, Sato K, Ikenoue H, Kuroda T, Inokuchi K, M F. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole. J Clin Endocrinol Metab. 1995;80:1904–1907.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir